Nevada News: Safety Information Regarding Fentora (Fentanyl Buccal Tablets)

January 1, 2008 10:33 am Topics: Patient safety

Reprinted from the January 2008 Nevada State Board of Pharmacy Newsletter.

Some serious adverse events have surfaced, including patient deaths, in patients treated with Fentora^® as a result of improper patient selection, improper dosing, and improper substitution. Per the manufacturer, the following are key safety points:
Fentora is not for opioid non-tolerant patients.

Fentora should not be used for acute pain, postoperative pain, headache, or sports injuries.
Fentora is not a generic for Actiq^® and may not be substituted without contacting the prescriber.

Dosing should be limited to not more than two tablets every four hours for breakthrough pain episodes.